"rituximab; splenectomy; anti-D globulin; immunoglobulins; corticosteroids; idiopathic thrombocytopenic purpura"@en . "Proch\u00E1zkov\u00E1, Jana" . "371345" . "Idiopatick\u00E1 trombocytopenick\u00E1 purpura" . . . "Jur\u00E1\u0148ov\u00E1, Jarmila" . . . "4"^^ . "RIV/61989592:15110/08:10223914!RIV12-MSM-15110___" . "Idiopatick\u00E1 trombocytopenick\u00E1 purpura (ITP) je onemocn\u011Bn\u00EDm, se kter\u00FDm se klinick\u00FD hematolog denn\u011B setk\u00E1v\u00E1 ve sv\u00E9 praxi. Incidence ITP je 6 nemocn\u00FDch na 100 000 obyvatel, p\u0159i\u010Dem\u017E t\u00E9m\u011B\u0159 polovinu pacient\u016F p\u0159edstavuj\u00ED d\u011Bti s dominuj\u00EDc\u00ED akutn\u00ED formou onemocn\u011Bn\u00ED. ITP dosp\u011Bl\u00FDch je zastoupena p\u0159ev\u00E1\u017En\u011B formou chronickou, \u010Dasto vy\u017Eaduj\u00EDc\u00ED opakovan\u00E9 l\u00E9\u010Debn\u00E9 intervence pro recidivy t\u011B\u017Ek\u00E9 trombocytopenie. V\u011Bkov\u00FD medi\u00E1n dosp\u011Bl\u00FDch pacient\u016F se pohybuje mezi 50-60 lety a u \u0159ady senior\u016F je klinick\u00E1 situace komplikov\u00E1na dal\u0161\u00EDmi onemocn\u011Bn\u00EDmi, jejich\u017E pr\u016Fb\u011Bh m\u016F\u017Ee b\u00FDt zhor\u0161en hematologickou l\u00E9\u010Dbou. Aktivn\u00ED ITP s v\u00FDznamnou trombocytopeni\u00ED tak nejednou nut\u00ED l\u00E9ka\u0159e r\u016Fzn\u00FDch specializac\u00ED modifikovat u t\u011Bchto pacient\u016F n\u011Bkter\u00E9 diagnostick\u00E9 nebo l\u00E9\u010Debn\u00E9 postupy." . . "4"^^ . . "Raida, Lud\u011Bk" . . . "[058900095D09]" . . "Hlu\u0161\u00ED, Anton\u00EDn" . "0032-6739" . . . "RIV/61989592:15110/08:10223914" . "Idiopatick\u00E1 trombocytopenick\u00E1 purpura (ITP) je onemocn\u011Bn\u00EDm, se kter\u00FDm se klinick\u00FD hematolog denn\u011B setk\u00E1v\u00E1 ve sv\u00E9 praxi. Incidence ITP je 6 nemocn\u00FDch na 100 000 obyvatel, p\u0159i\u010Dem\u017E t\u00E9m\u011B\u0159 polovinu pacient\u016F p\u0159edstavuj\u00ED d\u011Bti s dominuj\u00EDc\u00ED akutn\u00ED formou onemocn\u011Bn\u00ED. ITP dosp\u011Bl\u00FDch je zastoupena p\u0159ev\u00E1\u017En\u011B formou chronickou, \u010Dasto vy\u017Eaduj\u00EDc\u00ED opakovan\u00E9 l\u00E9\u010Debn\u00E9 intervence pro recidivy t\u011B\u017Ek\u00E9 trombocytopenie. V\u011Bkov\u00FD medi\u00E1n dosp\u011Bl\u00FDch pacient\u016F se pohybuje mezi 50-60 lety a u \u0159ady senior\u016F je klinick\u00E1 situace komplikov\u00E1na dal\u0161\u00EDmi onemocn\u011Bn\u00EDmi, jejich\u017E pr\u016Fb\u011Bh m\u016F\u017Ee b\u00FDt zhor\u0161en hematologickou l\u00E9\u010Dbou. Aktivn\u00ED ITP s v\u00FDznamnou trombocytopeni\u00ED tak nejednou nut\u00ED l\u00E9ka\u0159e r\u016Fzn\u00FDch specializac\u00ED modifikovat u t\u011Bchto pacient\u016F n\u011Bkter\u00E9 diagnostick\u00E9 nebo l\u00E9\u010Debn\u00E9 postupy."@cs . "Idiopathic thrombocytopenic purpura"@en . . "Praktick\u00FD l\u00E9ka\u0159" . "5"^^ . "Idiopathic thrombocytopenic purpura"@en . "Idiopathic thrombocytopenic purpura (ITP) is a disease commonly seen by the haematologist. The incidence of ITP is 6 patients per 100 000 people a year. Children, usually suffering from the acute form of ITP, represent approximately half of these patients. On the other hand, the majority of adult patients require repeated therapeutic intervention because of recurrent chronic ITP associated with severe thrombocytopenia. It normally affects adults between 50 and 60 years of age. Many elderly patients have a significant comorbidity and their health status can be made worse with haematological treatment. Patients with active ITP accompanied with significant thrombocytopenia may often have to be referred back to various specialists to modify some diagnostic and therapeutic approaches."@en . . . . . "Idiopatick\u00E1 trombocytopenick\u00E1 purpura"@cs . "Idiopatick\u00E1 trombocytopenick\u00E1 purpura"@cs . "Idiopatick\u00E1 trombocytopenick\u00E1 purpura" . "CZ - \u010Cesk\u00E1 republika" . . "12" . "15110" . . "S" . . . "88" .